By the end of the year, over 180,000 individuals are expected to take part in phase 3 clinical trials for vaccinations against coronavirus. Of the six trials listed, four have acquired U.S. taxpayer funding through the Biomedical Advanced Research and Development Authority (BARDA) or "U.S. Project Warp Speed". This statistic shows the number of expected phase 3 participants and BARDA/Warp Speed funding status of selected COVID-19 vaccines, by company, as of July 28, 2020.
Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Evaluate Vantage. (July 28, 2020). Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/
Evaluate Vantage. "Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company." Chart. July 28, 2020. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/
Evaluate Vantage. (2020). Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company. Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/
Evaluate Vantage. "Phase 3 Enrollment and Barda/Warp Speed Funding Status for Select Covid-19 Vaccines, as of July 28, 2020, by Company." Statista, Statista Inc., 28 Jul 2020, https://www.statista.com/statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/
Evaluate Vantage, Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company Statista, https://www.statista.com/statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/ (last visited December 21, 2024)
Phase 3 enrollment and BARDA/Warp Speed funding status for select COVID-19 vaccines, as of July 28, 2020, by company [Graph], Evaluate Vantage, July 28, 2020. [Online]. Available: https://www.statista.com/statistics/1139370/covid-vaccine-development-enrollment-funding-by-company/
